Sanders Urges Denmark to Pressure Novo Nordisk on Lowering Drug Prices
- US senator writes letter to one of the country’s main papers
- Novo is facing calls to lower prices for Ozempic and Wegovy
Packets of Ozempic move along a conveyor at the Novo Nordisk A/S production facilities in Hillerod, Denmark.
Photographer: Carsten Snejbjerg/BloombergThis article is for subscribers only.
Bernie Sanders urged Denmark to force its most valuable company, Novo Nordisk A/S, to lower its drug prices, in a letter submitted by the US senator to one of the Nordic country’s largest newspapers.
Sanders, who chairs the Senate’s Health, Education, Labor and Pensions Committee, called on Danes to pressure Novo to “significantly reduce the outrageously high prices for Ozempic and Wegovy in the US and other parts of the world,” according to the letter, published by the Politiken newspaper on Monday.